Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Recent advances in microbial and enzymatic engineering for the biodegradation of micro- and nanoplastics - Choi_2024_RSC.Adv_14_9943 |
| Author(s) : Choi J , Kim H , Ahn YR , Kim M , Yu S , Kim N , Lim SY , Park JA , Ha SJ , Lim KS , Kim HO |
| Ref : RSC Adv , 14 :9943 , 2024 |
| Abstract : Choi_2024_RSC.Adv_14_9943 |
| ESTHER : Choi_2024_RSC.Adv_14_9943 |
| PubMedSearch : Choi_2024_RSC.Adv_14_9943 |
| PubMedID: 38528920 |
| Title : Effects of dexamethasone coadministered with oseltamivir on the pharmacokinetics of oseltamivir in healthy volunteers - Jang_2017_Drug.Des.Devel.Ther_11_705 |
| Author(s) : Jang K , Kim MK , Oh J , Lee S , Cho JY , Yu KS , Choi TK , Lee SH , Lim KS |
| Ref : Drug Des Devel Ther , 11 :705 , 2017 |
| Abstract : Jang_2017_Drug.Des.Devel.Ther_11_705 |
| ESTHER : Jang_2017_Drug.Des.Devel.Ther_11_705 |
| PubMedSearch : Jang_2017_Drug.Des.Devel.Ther_11_705 |
| PubMedID: 28331290 |
| Title : The novel carboxylesterase 1 variant c.662A>G may decrease the bioactivation of oseltamivir in humans - Oh_2017_PLoS.One_12_e0176320 |
| Author(s) : Oh J , Lee S , Lee H , Cho JY , Yoon SH , Jang IJ , Yu KS , Lim KS |
| Ref : PLoS ONE , 12 :e0176320 , 2017 |
| Abstract : Oh_2017_PLoS.One_12_e0176320 |
| ESTHER : Oh_2017_PLoS.One_12_e0176320 |
| PubMedSearch : Oh_2017_PLoS.One_12_e0176320 |
| PubMedID: 28437488 |
| Title : Multiple-dose pharmacokinetics and pharmacodynamics of evogliptin (DA-1229), a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers - Gu_2014_Drug.Des.Devel.Ther_8_1709 |
| Author(s) : Gu N , Park MK , Kim TE , Bahng MY , Lim KS , Cho SH , Yoon SH , Cho JY , Jang IJ , Yu KS |
| Ref : Drug Des Devel Ther , 8 :1709 , 2014 |
| Abstract : Gu_2014_Drug.Des.Devel.Ther_8_1709 |
| ESTHER : Gu_2014_Drug.Des.Devel.Ther_8_1709 |
| PubMedSearch : Gu_2014_Drug.Des.Devel.Ther_8_1709 |
| PubMedID: 25336915 |
| Title : Pharmacokinetics and pharmacodynamics of LC15-0444, a novel dipeptidyl peptidase IV inhibitor, after multiple dosing in healthy volunteers - Lim_2009_Br.J.Clin.Pharmacol_68_883 |
| Author(s) : Lim KS , Cho JY , Kim BH , Kim JR , Kim HS , Kim DK , Kim SH , Yim HJ , Lee SH , Shin SG , Jang IJ , Yu KS |
| Ref : British Journal of Clinical Pharmacology , 68 :883 , 2009 |
| Abstract : Lim_2009_Br.J.Clin.Pharmacol_68_883 |
| ESTHER : Lim_2009_Br.J.Clin.Pharmacol_68_883 |
| PubMedSearch : Lim_2009_Br.J.Clin.Pharmacol_68_883 |
| PubMedID: 20002082 |
| Title : Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study - Lim_2008_Clin.Ther_30_1817 |
| Author(s) : Lim KS , Kim JR , Choi YJ , Shin KH , Kim KP , Hong JH , Cho JY , Shin HS , Yu KS , Shin SG , Kwon OH , Hwang DM , Kim JA , Jang IJ |
| Ref : Clin Ther , 30 :1817 , 2008 |
| Abstract : Lim_2008_Clin.Ther_30_1817 |
| ESTHER : Lim_2008_Clin.Ther_30_1817 |
| PubMedSearch : Lim_2008_Clin.Ther_30_1817 |
| PubMedID: 19014837 |